Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC1-containing store-operated calcium channels (SOCs) are heteromeric protein complexes that play a pivotal role in store-operated calcium entry (SOCE), a fundamental mechanism for regulating intracellular calcium levels. These channels are primarily composed of the Transient Receptor Potential Canonical 1 (TRPC1) protein, which functions in coordination with the endoplasmic reticulum (ER) calcium sensor STIM1 and the pore-forming protein Orai1. Upon the depletion of ER calcium stores, STIM1 undergoes a conformational change and translocates to ER-plasma membrane junctions, where it recruits and activates TRPC1 and Orai1 to facilitate calcium influx. This influx is essential for refilling internal stores and activating downstream signaling pathways involved in cell growth, motility, and survival. Dysregulation of TRPC1-containing SOCs is strongly linked to various diseases, including several types of cancer where they promote metastasis and chemoresistance, as well as cardiovascular conditions like cardiac hypertrophy and pulmonary hypertension. While these channels represent promising therapeutic targets, the development of effective drugs is hindered by the lack of highly selective inhibitors and the widespread physiological distribution of the channel components.
Inhibition of store-operated calcium entry (SOCE) by blocking the channel pore or disrupting the interaction between TRPC1 and its regulatory proteins STIM1 and Orai1.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential canonical 1-containing store-operated calcium channel (TRPC1-SOC).